Cargando…
Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187833/ https://www.ncbi.nlm.nih.gov/pubmed/32361326 http://dx.doi.org/10.1016/j.jcv.2020.104388 |